Serving the Health Care Community in Michigan’s Upper Peninsula
New-Drug Reviews Committee News

   Bystolic (nebivolol) (May 2008)

  Cyanokit (hydroxoccobalamin) (March 2008)

  Doribax (doripenem) (March 2008)

  Galvus (vildagliptin) (October 2007)

  Neupro (rotigotine) (September 2007)

   
Drug-Class Reviews

  Antiemetics (May 2008)

  Weight-Management Medications (May 2008)

  Anti-Alcohol Agents (March 2008)

  Carbapenems (March 2008)

  Histamine H2 Receptor Antagonists (March 2008)

  Opioid Agonists and Antagonists (March 2008)

   
    Next Meeting:  July 9, 2008
   Packets mailed on or about July 2.
    May 14:  Last committee meeting.
   Thank you for participating.
    Bystolic reviewed in May.
    Weight-management medications
   reviewed in May.
    Antiemetics reviewed in May.
    Cyanokit reviewed in March.
    Carbapenems and Doribax
   reviewed in March.
    Drugs related to substance abuse
   reviewed in March.
    Histamine H2-Receptor Antagonists
   reviewed in March.
    The UPHP and the UPHCN won a 2008
   Rx Benefit Innovation Award from
   the Pharmacy Benefit Management
   Institute in February. The award
   recognized both organizations for
   collaborating on the
   Community-Based Initiative to
   Manage Prescribing Cost and
                     Quality.      
    Symbicort reviewed in January.
    Inhaled corticosteroids reviewed in January.
    Intranasal corticosteroids reviewed in
   January.
    Less-sedating antihistamines reviewed in
   January.
    Echinocandins reviewed in November.

228 West Washington Street
Marquette, MI  49855
Telephone: (906) 225-7500  888-904-7526
Fax: (906) 225-7690

Webmaster

Disclaimer
A Collaboration of the Upper Peninsula Health Plan and the Upper Peninsula Health Care Network
Promoting Rational, Clinically Appropriate, Safe, and Cost-Effective Pharmaceutical Care in the Upper Peninsula

[Home] [Clinical] [The Committee] [Contact Us] [Links] [Policies]